Sartorius Stedim Biotech S.A. SDMHF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 6.04% | 4.04% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 6.04% | 4.04% | |
| Cost of Revenue | -- | -- | 0.64% | 0.71% | |
| Gross Profit | -- | -- | 13.60% | 8.64% | |
| SG&A Expenses | -- | -- | 4.22% | 3.00% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | 151.47% | 139.94% | |
| Total Operating Expenses | -- | -- | 6.11% | 5.56% | |
| Operating Income | -- | -- | 5.64% | -3.86% | |
| Income Before Tax | -- | -- | 14.80% | -26.18% | |
| Income Tax Expenses | -- | -- | -11.77% | -33.80% | |
| Earnings from Continuing Operations | -- | -- | 24.43% | -24.03% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | 66.41% | 20.58% | |
| Net Income | -- | -- | 26.41% | -24.07% | |
| EBIT | -- | -- | 5.64% | -3.86% | |
| EBITDA | -- | -- | 5.52% | 1.73% | |
| EPS Basic | -- | -- | 22.76% | -26.72% | |
| Normalized Basic EPS | -- | -- | 171.15% | -17.49% | |
| EPS Diluted | -- | -- | 22.76% | -26.72% | |
| Normalized Diluted EPS | -- | -- | 171.15% | -17.49% | |
| Average Basic Shares Outstanding | -- | -- | 3.36% | 3.41% | |
| Average Diluted Shares Outstanding | -- | -- | 3.36% | 3.41% | |
| Dividend Per Share | -- | -- | -0.98% | -0.98% | |
| Payout Ratio | -- | -- | -0.17% | -- | |